HOME >> MEDICINE >> NEWS
JCI table of contents: December 8, 2005

EDITOR'S PICK

Alzheimer's disease prevention may be easier than cure

Current hypotheses suggest that it is the accumulation over time of amyloid beta peptide 142 (Abeta42) that triggers changes in the brain that lead to cognitive dysfunction in Alzheimer's disease. The reduction of amyloid levels is therefore a major therapeutic objective. Todd Golde and colleagues from the Mayo Clinic Jacksonville report evidence to suggest that prevention of amyloid deposition may be easier than curing established Alzheimer's disease. Their results will appear online on December 8 in advance of print publication in the January 2006 issue of the Journal of Clinical Investigation.

The authors use transgenic mice genetically predisposed to accumulate amyloid deposits in their brain to show that an immunization strategy targeting Abeta42, or a second form of Abeta known as Abeta40, prevents the onset of amyloid deposition in these mice at a young age. In contrast, the anti-Abeta42 or anti-Abeta40 monoclonal antibodies were not effective in altering Abeta deposition in mice with modest levels of preexisting Abeta deposits, nor were they capable of clearing existing deposits. The results suggest that it may be easier to prevent Abeta deposition than to alter Abeta once deposited. This method may be an effective strategy to prevent amyloid deposition prior to the onset of Alzheimer's disease, but may have limited benefit in a therapeutic setting where amyloid deposits are already well established within the brain.

TITLE: Anti-Abeta42 and Anti-Abeta40specific monoclonal antibodies attenuate amyloid deposition in an Alzheimer disease mouse model

AUTHOR CONTACT:

Todd E. Golde
Mayo Clinic Jacksonville, Florida, USA.
Phone: 904-953-2538; Fax: 904-953-7370; E-mail: tgolde@mayo.edu

View the PDF of this article at:

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
8-Dec-2005


Page: 1 2 3 4 5

Related medicine news :

1. International symposium on fruit, vegetables headed for Houston
2. Stevens Roundtable: Health, Technology & Society, July 11
3. FDA approves ZYFLO CR extended-release tablets for chronic treatment of asthma
4. Once-fatal metabolic disorders treatable, says Stanford/Packard researcher
5. Clinical review -- A psychological approach to the management of irritable bowel syndrome
6. JCI table of contents -- May 17, 2007
7. JCI table of contents: May 10, 2007
8. New treatments needed for irritable bowel syndrome
9. JCI table of contents: May 1, 2007
10. Americans still not eating enough fruits and vegetables, according to 2 recent studies
11. Slow-release morphine reduces level of intractable cough

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... ... A July 26 article on Reader’s Digest discusses how at least ... day. The acknowledges that, with dogs not always cooperating with being brushed, many owners ... least twice a week is likely enough to keep canines healthy. The article does ...
(Date:8/19/2019)... ... 18, 2019 , ... More Labs ( http://www.morelabs.com ), the ... SKUs to its line of functional offerings. Aqua+ is an oral rehydration solution ... Aqua+ from other rehydration solutions is the added benefits. On top of electrolytes, ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... Cannabinoid Biosciences ... non-pharmaceutical cannabidiol (CBD) products across the CBD market in the United States in ... campaign to raise $50 million on September 9, 2019. , Established on May ...
(Date:8/16/2019)... ... August 16, 2019 , ... The employees ... children’s aircraft to Ronald McDonald House Charities in New Hyde Park, Long Island, ... medical treatments and their family members a comfortable and fun way to watch ...
Breaking Medicine News(10 mins):
(Date:8/17/2019)... ... 17, 2019 , ... Inc. Magazine Unveils Its Annual List ... 2502 on the 2019 Inc. 5000 with Three-Year Revenue Growth of 157% Percent ... firm is No. 2502 on its annual Inc. 5000 list, the most prestigious ...
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center has ... Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The one-day ... Heights, is aimed at helping Houston families get their children caught up on ...
(Date:8/16/2019)... ... August 16, 2019 , ... Quantum Genomics are the creators ... hypertension by acting in the brain to interfere with the renin-angiotensin system. , ... affected by treatment-resistant hypertension, resulting in almost 10 million deaths per year from ...
Breaking Medicine Technology:
Cached News: